Search clinical trials for: NicoDerm CQ patch (GSK Dungarvan)

Total 171 results

HALEON

Completed

A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers

Tobacco Use Disorder

United States
Massachusetts General Hospital
Stanley Medical Research Institute; North Suffolk Mental Health Association

Completed

The Effects of Nicotine on Cognition in Schizophrenia

Schizophrenia

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy

Alcohol Drinking

United States
Ochsner Health System

Withdrawn

Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV)

Postoperative Nausea and Vomiting

United States
Medical University of South Carolina

Completed

Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes (BIRCWH)

Nicotine Dependence

United States
University of Pennsylvania
National Institutes of Health (NIH)

Completed

Nicotine Patch, Blood Flow and Oxidative Stress Study

Healthy

United States
University of Wisconsin, Madison
Washington University School of Medicine; National Heart, Lung, and Blood Institute...

Completed

UW Quitting Using Intensive Treatment Study (QUITS) (QUITS)

Tobacco Dependence

United States
Chrono Therapeutics, Inc.

Completed

Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects

Smoking Cessation

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

Tobacco Use Disorder

United States
Vanderbilt University Medical Center
National Institute of Mental Health (NIMH)

Recruiting

Depressed Mood Improvement Through Nicotine Dosing 3 (DepMIND3)

Depressive Disorder

United States
Duke University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)

Cigarette Smoking

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Physical Activity in Promoting Smoking Cessation in African Americans

Current Smoker | Healthy Subject

United States
Vanderbilt University Medical Center
National Institute of Mental Health (NIMH)

Recruiting

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Depressive Disorder

United States
University of Minnesota
National Institute on Drug Abuse (NIDA)

Completed

Innovative Interventions for Smoking Cessation

Tobacco Use Disorder

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking

Current Every Day Smoker

United States
Vanderbilt University Medical Center

Completed

Depressed Mood Improvement Through Nicotine Dosing 2 (DepMIND2)

Depressive Disorder

United States
Sir Mortimer B. Davis - Jewish General Hospital
Canadian Tobacco Control Research Initiative

Suspended

The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome (STADIA)

Smoking Cessation

Canada
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Cognition and Smoking Relapse (HCS) (HCS)

Smoking Cessation

United States
University of Maryland, College Park
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

Smoking

United States
University of Virginia

Completed

QuitAid Pilot Feasibility Trial

Smoking Cessation

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Varenicline and Combined NRT for Smoking Cessation

Tobacco Use Disorder | Cigarette Smoker

United States
Medical University of South Carolina

Completed

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

Nicotine Dependence

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas

Recruiting

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

Smoking | Lung Cancer

United States
University of Vermont
National Cancer Institute (NCI)

Completed

Treatment of Smoking Lapses and Relapses

Smoking Cessation

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Enrolling by invitation

Tobacco Treatment Comparison for Cancer Care

Smoking Cessation | Cancer

United States
University of Maryland, College Park
American Cancer Society, Inc.

Completed

Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment (BA-DAS)

Drug Use | Cigarette Smoking

United States
M.D. Anderson Cancer Center

Withdrawn

Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II

Smoking Cessation

United States
University of Maryland, College Park
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms

Cigarette Smoking

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Pharmacogenetics of Nicotine Addiction Treatment

Nicotine Addiction

United States, Canada
University of California, Los Angeles
University of California

Unknown

Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk (START)

Smoking | Cardiovascular Disease Risk

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation (STEP)

Smoking Cessation

Canada
Fujian Akeylink Biotechnology Co., Ltd.

Recruiting

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Chronic Hepatitis B

China
Washington University School of Medicine
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Genetically Informed Smoking Cessation Trial (GISC)

Smoking Cessation

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (RW)

Smoking Cessation | Psychiatric Illness

Canada
Francis McClernon, Ph.D.
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue) (VLNCCue)

Cigarette Smoking

United States
Maggie M Sweitzer, PhD
National Institute on Drug Abuse (NIDA)

Completed

Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation

Smoking

United States
Brown University
National Institute on Drug Abuse (NIDA)

Completed

Contingency Management for Smoking in Substance Abusers (SCMSUD)

Substance Abuse

United States
Duke University
National Cancer Institute (NCI)

Terminated

Testing Pharmacological Therapies for Pregnant Smokers

Smoking | Pregnancy

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation

Tobacco Use Disorder | Cigarette Smoker

United States
University of California, San Francisco

Completed

The END Perioperative Smoking Pilot Study

Smoking | Surgery | Nicotine Addiction

United States
University of Maryland, Baltimore
Food and Drug Administration (FDA)

Completed

Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers

Smoking

United States
Rabin Medical Center

Unknown

The Analgesic Effect of Nitroglycerin Patch for Postoperative Pain After Total Knee Replacement

Total Knee Arthroplasty

Israel
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

Coronary Heart Disease

Canada
University of California, San Francisco

Completed

Symptom Management After Breast Cancer Surgery

Neuropathic Pain | Postmastectomy Pain

United States
Vanderbilt University Medical Center

Completed

Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)

Major Depressive Disorder

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Combination Nicotine Replacement for Alcoholic Smokers

Smoking | Alcoholism

United States
University of Pennsylvania
National Cancer Institute (NCI)

Completed

Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)

Smoking

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

Coping Skills Treatment for Smoking Cessation (Project-WIN)

Nicotine Dependence

United States
Centre for Addiction and Mental Health
Ottawa Heart Institute Research Corporation; Canadian Cancer Society (CCS)

Completed

Personalized Dosing of Nicotine Replacement (NRT to Effect)

Tobacco Use Disorder | Nicotine Dependence

Canada
Centre for Addiction and Mental Health

Completed

Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation

Nicotine Dependence

Canada

Search clinical trials for: NicoDerm CQ patch (GSK Dungarvan)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations